Here it is... Primary concern is with my Lipid Panel. I started a keto lifestyle about 2 months ago due to my LDL levels and it doesn't look like it's improved... The report is telling me to start on statins... I do not want to do this. Also looks as if my estrogen is elevated...
CBC With Differential/Platelet
WBC 5.5 x10E3/uL 3.4 - 10.8 01
RBC 5.23 x10E6/uL 4.14 - 5.80 01
Hemoglobin 16.5 g/dL 12.6 - 17.7 01
Hematocrit 48.7 % 37.5 - 51.0 01
MCV 93 fL 79 - 97 01
MCH 31.5 pg 26.6 - 33.0 01
MCHC 33.9 g/dL 31.5 - 35.7 01
RDW 14.0 % 12.3 - 15.4 01
Platelets 195 x10E3/uL 150 - 379 01
Neutrophils 53 % 01
Lymphs 35 % 01
Monocytes 9 % 01
Eos 2 % 01
Basos 1 % 01
Neutrophils (Absolute) 3.0 x10E3/uL 1.4 - 7.0 01
Lymphs (Absolute) 1.9 x10E3/uL 0.7 - 3.1 01
Monocytes(Absolute) 0.5 x10E3/uL 0.1 - 0.9 01
Eos (Absolute) 0.1 x10E3/uL 0.0 - 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01
Comp. Metabolic Panel (14)
Glucose, Serum 72 mg/dL 65 - 99 01
BUN 19 mg/dL 6 - 24 01
Creatinine, Serum 1.22 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 74 mL/min/1.73 >59
eGFR If Africn Am 85 mL/min/1.73 >59
BUN/Creatinine Ratio 16 9 - 20
Sodium, Serum 138 mmol/L 134 - 144 01
Potassium, Serum 4.4 mmol/L 3.5 - 5.2 01
Chloride, Serum 98 mmol/L 97 - 108 01
Carbon Dioxide, Total 23 mmol/L 18 - 29 01
Calcium, Serum 9.2 mg/dL 8.7 - 10.2 01
Protein, Total, Serum 6.7 g/dL 6.0 - 8.5 01
Albumin, Serum 4.5 g/dL 3.5 - 5.5 01
Globulin, Total 2.2 g/dL 1.5 - 4.5
A/G Ratio 2.0 1.1 - 2.5
Bilirubin, Total 0.6 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 42 IU/L 39 - 117 01
AST (SGOT) 29 IU/L 0 - 40 01
ALT (SGPT) 35 IU/L 0 - 44 01
Lipid Panel w/ Chol/HDL Ratio
Cholesterol, Total 292 High mg/dL 100 - 199 01
Triglycerides 68 mg/dL 0 - 149 01
HDL Cholesterol 56 mg/dL >39 01
Comment 01
According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 14 mg/dL 5 - 40
LDL Cholesterol Calc 222 High mg/dL 0 - 99
Comment:
Possible Familial Hypercholesterolemia. FH should be suspected when
fasting LDL cholesterol is above 189 mg/dL or non-HDL cholesterol
is above 219 mg/dL. A family history of high cholesterol and heart
disease in 1st degree relatives should be collected. J Clin Lipidol
2011;5:133-140
T. Chol/HDL Ratio 5.2 High ratio units 0.0 - 5.0
Please Note: 01
T. Chol/HDL Ratio
Men Women
1/2 Avg.Risk 3.4 3.3
Avg.Risk 5.0 4.4
2X Avg.Risk 9.6 7.1
3X Avg.Risk 23.4 11.0
Testosterone,Free and Total
Testosterone, Serum 851 ng/dL 348 - 1197 01
Comment:
Adult male reference interval is based on a population of lean males
up to 40 years old.
Free Testosterone(Direct) 22.2 High pg/mL 6.8 - 21.5 02
DHEA-Sulfate 421.0 High ug/dL 102.6 - 416.3 01
TSH 1.040 uIU/mL 0.450 - 4.500 01
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
Estradiol, Sensitive 56.2 High pg/mL 8.0 - 35.0 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Triiodothyronine,Free,Serum 2.9 pg/mL 2.0 - 4.4 01
CBC With Differential/Platelet
WBC 5.5 x10E3/uL 3.4 - 10.8 01
RBC 5.23 x10E6/uL 4.14 - 5.80 01
Hemoglobin 16.5 g/dL 12.6 - 17.7 01
Hematocrit 48.7 % 37.5 - 51.0 01
MCV 93 fL 79 - 97 01
MCH 31.5 pg 26.6 - 33.0 01
MCHC 33.9 g/dL 31.5 - 35.7 01
RDW 14.0 % 12.3 - 15.4 01
Platelets 195 x10E3/uL 150 - 379 01
Neutrophils 53 % 01
Lymphs 35 % 01
Monocytes 9 % 01
Eos 2 % 01
Basos 1 % 01
Neutrophils (Absolute) 3.0 x10E3/uL 1.4 - 7.0 01
Lymphs (Absolute) 1.9 x10E3/uL 0.7 - 3.1 01
Monocytes(Absolute) 0.5 x10E3/uL 0.1 - 0.9 01
Eos (Absolute) 0.1 x10E3/uL 0.0 - 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01
Comp. Metabolic Panel (14)
Glucose, Serum 72 mg/dL 65 - 99 01
BUN 19 mg/dL 6 - 24 01
Creatinine, Serum 1.22 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 74 mL/min/1.73 >59
eGFR If Africn Am 85 mL/min/1.73 >59
BUN/Creatinine Ratio 16 9 - 20
Sodium, Serum 138 mmol/L 134 - 144 01
Potassium, Serum 4.4 mmol/L 3.5 - 5.2 01
Chloride, Serum 98 mmol/L 97 - 108 01
Carbon Dioxide, Total 23 mmol/L 18 - 29 01
Calcium, Serum 9.2 mg/dL 8.7 - 10.2 01
Protein, Total, Serum 6.7 g/dL 6.0 - 8.5 01
Albumin, Serum 4.5 g/dL 3.5 - 5.5 01
Globulin, Total 2.2 g/dL 1.5 - 4.5
A/G Ratio 2.0 1.1 - 2.5
Bilirubin, Total 0.6 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 42 IU/L 39 - 117 01
AST (SGOT) 29 IU/L 0 - 40 01
ALT (SGPT) 35 IU/L 0 - 44 01
Lipid Panel w/ Chol/HDL Ratio
Cholesterol, Total 292 High mg/dL 100 - 199 01
Triglycerides 68 mg/dL 0 - 149 01
HDL Cholesterol 56 mg/dL >39 01
Comment 01
According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 14 mg/dL 5 - 40
LDL Cholesterol Calc 222 High mg/dL 0 - 99
Comment:
Possible Familial Hypercholesterolemia. FH should be suspected when
fasting LDL cholesterol is above 189 mg/dL or non-HDL cholesterol
is above 219 mg/dL. A family history of high cholesterol and heart
disease in 1st degree relatives should be collected. J Clin Lipidol
2011;5:133-140
T. Chol/HDL Ratio 5.2 High ratio units 0.0 - 5.0
Please Note: 01
T. Chol/HDL Ratio
Men Women
1/2 Avg.Risk 3.4 3.3
Avg.Risk 5.0 4.4
2X Avg.Risk 9.6 7.1
3X Avg.Risk 23.4 11.0
Testosterone,Free and Total
Testosterone, Serum 851 ng/dL 348 - 1197 01
Comment:
Adult male reference interval is based on a population of lean males
up to 40 years old.
Free Testosterone(Direct) 22.2 High pg/mL 6.8 - 21.5 02
DHEA-Sulfate 421.0 High ug/dL 102.6 - 416.3 01
TSH 1.040 uIU/mL 0.450 - 4.500 01
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
Estradiol, Sensitive 56.2 High pg/mL 8.0 - 35.0 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Triiodothyronine,Free,Serum 2.9 pg/mL 2.0 - 4.4 01